Nutrient quality
A bioavailable form provides focused support for glucose handling. The unusually high amount reduces dose quality and long-term balance.
| $ 11.02 | ||
Vitacost | $ 7.45 | |
Daily Vita | $ 8.10 | |
| $ 7.34 |
The capsule supplies 1,000 mcg chromium as chromium picolinate, a clearly identified source aimed at normal insulin action and carbohydrate handling. Its practical benefit is most plausible when chromium intake or glucose regulation is suboptimal.
Chromium does not reliably create satiety, thermogenesis, or meaningful weight loss on its own. The single-active design gives one pathway good depth but leaves appetite, protein intake, muscle preservation, and energy expenditure unaddressed.
The amount is unusually high for routine supplementation and adds exposure without broadening the formula. The ingredient listing also conflicts with the lower amount in the product name, so the original package should be checked. People using glucose-lowering medicine need to consider additive effects.
A bioavailable form provides focused support for glucose handling. The unusually high amount reduces dose quality and long-term balance.
The chromium form and total amount are visible without a hidden blend. Elemental-yield detail, full directions, and inactive ingredients are incomplete.
The aggregate rating is exceptionally strong and the evidence base is very large. Specific experience details are unavailable, so complaint patterns and purpose fit remain uncertain.
Favorable form quality and strong dose-normalized economy support value. The unusually high serving limits practical competitiveness.
Chromium picolinate targets insulin signaling and glucose handling, making it relevant when glycemic control is impaired. Evidence for increasing metabolic rate or producing weight loss is inconsistent, especially in people without chromium deficiency.
The picolinate form is well disclosed, but the 1000 mcg amount is high relative to common supplemental use. Chromium can lower blood glucose, so this serving may increase hypoglycemia risk when combined with insulin or sulfonylurea medicines.
Chromium picolinate may support glucose handling and cravings in people with impaired insulin sensitivity. The 1000 mcg amount provides a clearly disclosed, targeted serving.
Human effects on appetite or body weight are inconsistent, and the single nutrient does not directly create satiety or meaningful thermogenesis. The formula is best viewed as situational metabolic support rather than a stand-alone weight-loss approach.
| Ingredient | Amount per serving |
|---|---|
Chromium (Chromium Picolinate) | 1000 mcg |
Chromium picolinate provides a bioavailable form, but the 1,000 mcg serving sits at the top of the stated high-potency range. The active dose is very economical after adjusting for its size. A generic source and ambiguous elemental-weight labeling limit quality and transparency.
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.